New NICE STA process

ISPOR 2020 Has the new NICE STA process addressed inefficiencies within the appraisal process?


Historically, the National Institute of Health and Care Excellence (NICE) appraisal process has been resource intensive, with most drugs requiring two committee meetings prior to receiving a positive NICE outcome. To address this, in April 2018, NICE began the roll-out of a new single technology appraisal (STA) process, incorporating a technical engagement phase to resolve any issues within submissions prior to committee meetings. This study aimed to assess whether the new process has resulted in changes to outcomes of STAs.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.